FIRPLUZA

Pharmaceutical products and preparations for the prevention and treatment of lysosomal storage disorders, in particular Gaucher Disease, as well as of diseases and disorders affecting the central and peripheral nervous systems, including movement disorders, Parkinson's disease, and related parkinsonian conditions.